What is behind Abbott Laboratories stock's recent drop in value today

Traders Union
All News
Financial News
Abbott laboratories slides 2.04% today

Highlights

Abbott Laboratories trades below key moving averages, reflecting sustained bearish momentum and pressure from sellers.
Short- and medium-term technical indicators favor further decline, with momentum mixed but no buy signals from weekly gauges.
Price is expected to consolidate between $83.91 and $90.43 over the next five sessions unless momentum shifts materially.

Anton Kharitonov, expert at Traders Union, sees continued weakness in Abbott Laboratories as it trades below all major moving averages. He believes the lack of news support on key dates highlights a lack of catalysts for recovery. Technical indicators point to persistent bearish sentiment, with only minor divergence among oscillators preventing a deeper decline. The expert warns that failing to hold $87.27 could trigger further downside toward $83.91. "Current setups do not justify long positions — any sign of strength may be short-lived until fundamental drivers reappear."

Viktoras Karapetjanc, expert at Traders Union, sees the technical correction as an opportunity for patient investors. He notes that while bearish forces dominate now, the market often offers setups for long-term growth after consolidation. The absence of material news flow does not change his constructive outlook for the stock's fundamentals. "Consolidation above $87.27 suggests room for accumulation, and I expect bullish structure to recover above $90.43 in the coming sessions if buyers step in energetically."

Parshwa Turakhiya, analyst, notes that sentiment for ABT is mixed as technicals show both bearish pressure and signs of exhaustion. He points out that most momentum indicators are neutral or sending contradictory signals, which could trigger rapid short-term swings. The analyst believes traders should look for intraday volatility spikes as entry or exit cues within the projected $83.91–$90.43 range. "A break either side of this range can quickly shift sentiment, so flexibility and readiness are key for the next few sessions."

Mixed momentum as bearish bias meets oscillator divergence

This technical setup indicates sustained selling pressure in both the short and medium term and confirms a longer-term bearish structure for ABT. The nearest dynamic support is aligned with the Ichimoku Kijun level at $87.27, while resistance stands at the 50-day moving average near $91.50. Momentum indicators show a mildly negative tone: the daily MACD is neutral, ADX signals early strength for sellers, and RSI is mid-range but flashing a buy. The Stochastic RSI and CCI are neutral to modestly overbought. Bull/Bear Power highlights that buyers still have influence, but with an 'overbought' warning signal. Intraday volatility has reached 3.00%, and the stock has traded lower toward the bottom of its daily range. However, there’s divergence among oscillators as the bearish price action is not fully supported by all indicators.

Earlier, analysts noted that Abbott Laboratories was entrenched in a prevailing bearish trend, with technical signals favoring continued consolidation and downside risk. This latest analysis reinforces that perspective amid persistently negative momentum, highlighting the importance of monitoring for a potential break below the $83.91 support band as the next pivotal move.

Source of Data: ABT Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.